Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Will Combine Two Units Into One

Click here for an updated version of this story.

 

NEW YORK, Oct. 29 - PerkinElmer today said it will combine its Life Sciences and Analytical Instruments business units into a new division called Life and Analytical Sciences.

Peter Coggins, formerly president of the Life Sciences unit, will be president of the new organization, which takes shape "immediately." Stephen DeFalco, the current president of Analytical Instruments, will help with the transition through the end of the year.

 

It was not immediately clear whether he will stay on in the new unit. It was also not immediately know whether the new business will retain all of the staff that currently works for Life Sciences and Analytical Instruments. The combined unit has approximately $1 billion in revenue, more than 2,000 sales, service, and applications employees, and an annual R&D budget of around $65 million, according to PerkinElmer.

The Life and Analytical Sciences will be headquartered in Boston, and PerkinElmer will "continue to maintain a significant presence" in Shelton, Conn., former headquarters of the Analytical Instruments unit.

The new unit "will enable PerkinElmer to provide a single, unified face" to its customers and "bring greater resources to our analytical customers," said Gregory Summe, chairman and CEO of PerkinElmer. "It also enables us to better leverage our R&D investment, global sales and service network, and operational capabilities."

 

Click here for more information.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.